CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4/A Shares withheld for taxes Chief Business Officer gave up 1,102 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise Chief Legal Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief Medical Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief People Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief Business Officer acquired 3,750 shares (option exercise)
- 4 Option exercise President & CEO acquired 12,500 shares (option exercise)
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Chief Scientific Officer acquired 28,084 shares (option exercise)
- 4 Open-market buy President & CEO bought 10,000 shares at $8.40 ($84,000)
- 8-K Event Other events
- 4 Grant or award Director acquired 379 shares (grant or award)
Page 19 of 28 · 549 filings